Merck KGaA (OTCMKTS:MKGAF) Sees Large Volume Increase - Should You Buy?

Key Points

• Merck KGaA experienced a significant increase in trading volume, with 4,151 shares traded, marking a 332% rise from the previous session.
• The stock price rose 2.5% to $128.72, compared to its previous close of $126.10.
• Merck KGaA is a science and technology company with a market cap of $16.71 billion and operates through multiple segments including Life Science and Healthcare.

Merck KGaA (OTCMKTS:MKGAF - ) shares saw an uptick in trading volume on Monday . 4,151 shares changed hands during trading, an increase of 332% from the previous session's volume of 960 shares.The stock last traded at $128.72 and had previously closed at $126.10.

Merck KGaA Trading Up 2.5%

The stock has a market capitalization of $16.71 billion, a price-to-earnings ratio of 19.74 and a beta of 0.96. The company's 50 day moving average is $129.07 and its 200 day moving average is $132.46. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.